| Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The potential applications of this process address clinical needs such as vascular disease, heart valve replacement and knee repair. |
|
